Roivant Sciences officer lists $7.32M in shares for sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Roivant Sciences Ltd. officer Richard Pulik’s amended notice lists 175,000 common shares for sale, with an aggregate market value of $7,323,568.07 and an approximate sale date of November 11, 2026. The notice also reports 125,000 shares sold on November 10, 2026, for gross proceeds of $5,150,575.00.
Key Figures
Key Terms
Restricted Stock Vesting Under a Registered Plan financial
Employee Stock Purchase Plan financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why were Richard Pulik’s ROIV sales from November 11 reported the next day?
AI-generated analysis. How Rhea-AI works. Not financial advice.